NATCO Pharma Limited (NATCOPHARM)
₹877.75
INR+4.90(+0.56%)
As of June 18, 2025 9:39:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹16161.99 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹13530.20 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
8.58
Forward P/E
Price to Earnings ratio based on forecasted earnings
21.86
PEG Ratio
Price/Earnings to Growth ratio
21.86
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
3.65
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
79.59%
Operating Margin
Operating income as a percentage of revenue
36.84%
Return on Equity
Net income as a percentage of shareholders' equity
27.97%
Revenue (TTM)
Total revenue over trailing 12 months
₹4429.50 Cr+14.000000000000002%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹2550.50 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹105.23+5.3%
Balance Sheet
Total Cash
Total cash and short-term investments
₹2917.30 Cr
Total Debt
Total short-term and long-term debt
₹279.40 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
3.67%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹726.8 - ₹1639
Beta
Measure of stock's volatility compared to the market
0.31
Shares Outstanding
Total number of shares issued by the company
₹17.91 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
58.95%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
71.23%
Payout Ratio
Percentage of earnings paid as dividends
5.70%
